Therapeutic and immunomodulatory activities of short-course treatment of murine visceral leishmaniasis with KALSOME™10, a new liposomal amphotericin B
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Therapeutic and immunomodulatory activities of short-course treatment of murine visceral leishmaniasis with KALSOME™10, a new liposomal amphotericin B
Authors
Keywords
Drug, Liposomal amphotericin B, <em class=EmphasisTypeItalic >Leishmania</em>, Efficacy, Toxicity, Immunomodulation, Cytokine, Immune response
Journal
BMC INFECTIOUS DISEASES
Volume 15, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-04-16
DOI
10.1186/s12879-015-0928-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Complete Cure of Experimental Visceral Leishmaniasis with Amphotericin B in Stearylamine-Bearing Cationic Liposomes Involves Down-Regulation of IL-10 and Favorable T Cell Responses
- (2014) A. Banerjee et al. JOURNAL OF IMMUNOLOGY
- Asparagus racemosus ameliorates cisplatin induced toxicities and augments its antileishmanial activity by immunomodulation in vivo
- (2013) Heena Sachdeva et al. PARASITOLOGY INTERNATIONAL
- Involvement and interactions of different immune cells and their cytokines in human visceral leishmaniasis
- (2013) Pradyot Bhattacharya et al. Revista da Sociedade Brasileira de Medicina Tropical
- Developments in diagnosis and treatment of visceral leishmaniasis during the last decade and future prospects
- (2012) Sarfaraz Ahmad Ejazi et al. Expert Review of Anti-Infective Therapy
- Relapse of kala-azar after use of multiple drugs: A case report and brief review of literature
- (2012) K Pandey et al. Indian Journal of Medical Microbiology
- Evaluation of Leishmania donovani Protein Disulfide Isomerase as a Potential Immunogenic Protein/Vaccine Candidate against Visceral Leishmaniasis
- (2012) Pramod Kumar Kushawaha et al. PLoS One
- Leishmaniasis Worldwide and Global Estimates of Its Incidence
- (2012) Jorge Alvar et al. PLoS One
- Natural killer cells in experimental and human leishmaniasis
- (2012) Christian Bogdan Frontiers in Cellular and Infection Microbiology
- Combination Therapy with Paromomycin-Associated Stearylamine-Bearing Liposomes Cures Experimental Visceral Leishmaniasis through Th1-Biased Immunomodulation
- (2011) Antara Banerjee et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Leishmaniasis chemotherapy—challenges and opportunities
- (2011) S.L. Croft et al. CLINICAL MICROBIOLOGY AND INFECTION
- Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial
- (2011) Shyam Sundar et al. LANCET
- Therapy with Sodium Stibogluconate in Stearylamine-Bearing Liposomes Confers Cure against SSG-Resistant Leishmania donovani in BALB/c Mice
- (2011) Jayeeta Roychoudhury et al. PLoS One
- A rare case of Visceral leishmaniasis with multiple relapse and multi-drug unresponsive: successfully treated with combination therapy
- (2011) Nawin Kumar et al. International Journal of Clinical Pharmacy
- Current diagnosis and treatment of visceral leishmaniasis
- (2010) Smriti Mondal et al. Expert Review of Anti-Infective Therapy
- Immunoactivation and immunopathogeny during active visceral leishmaniasis
- (2010) Hiro Goto et al. REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO
- A Curative Immune Profile One Week after Treatment of Indian Kala-Azar Patients Predicts Success with a Short-Course Liposomal Amphotericin B Therapy
- (2010) Smriti Mondal et al. PLoS Neglected Tropical Diseases
- Liposomal amphotericin B: what is its role in 2008?
- (2008) F. Lanternier et al. CLINICAL MICROBIOLOGY AND INFECTION
- Paromomycin in the treatment of leishmaniasis
- (2008) Shyam Sundar et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Safety of a pre-formulated amphotericin B lipid emulsion for the treatment of Indian Kala-azar
- (2008) S. Sundar et al. TROPICAL MEDICINE & INTERNATIONAL HEALTH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More